SUN VALLEY, CA–(Marketwire – March 10, 2010) –  XTend Medical (PINKSHEETS: XMDC), a company that specializes in delivering life-changing medical technology to healthcare organizations globally, announced today that the company has filed legal action against U & I Bio-Tech, Korea and California, as well as Mr. Sam Lee personally, for their failure to deliver all BioHarp-related assets acquired pursuant to the Asset Purchase Agreement signed on December 8, 2009. The case, captioned as XTend Medical Corp. v. Lee, was filed on Monday, March 8, 2010 and is pending in the United States District Court for the Central District of California as Case No, 2:10-CV-01681 DMG (JEMx).